摘要:
A computing device determines counts of documents that are similar to a reference document for a set of similarity ratings. Each similarity rating is based on a number of co-occurring terms between the reference document and corresponding similar documents. The computing device present the reference document and a GUI element pertaining to the documents similar to the reference document in a graphical user interface (GUI). Upon a selection of the GUI element, the computing device presents a visual representation of a correlation between the counts of similar documents and the similarity ratings in the GUI. The visual representation is provided prior to displaying at least one of the similar documents.
摘要:
Compounds of formula (I) are ligands of the CRTH2 receptor and are useful in the treatment of respiratory disease: Formula (I) wherein R1, R2, R3 and R4 each independently are hydrogen, C1C6alkyl, fully or partially fluorinated C1C6alkyl, halo, —S(O)nR10, —SO2N(R10)2, —N(R10)2, —C(O)N(R10)2, —NR10C(O)R9, —CO2R10, —C(O)R9, —NO2, —CN or —OR11; wherein each R9 is independently C1C6alkyl, aryl, heteroaryl; R10 is independently hydrogen, C1C6alkyl, aryl, or heteroaryl; R11 is hydrogen, C1C6alkyl, fully or partially fluorinated C1C6alkyl or a group —SO2R9; n is 0, 1 or 2; R5 is C1C6alkyl, fully or partially fluorinated C1C6alkyl. C1C6alkenyl, C1C6alkynyl, optionally substituted aryl, or optionally substituted heteroaryl; R6 is hydrogen, C1C6alkyl or fully or partially fluorinated C1C6alkyl; R7 and R5 are independently hydrogen or C1C6alkyl, or R7 and R5 together with the atom to which they are attached form a cycloalkyl group; and X is —CHR6—, —S(O)n—, —NR6SO2— or —SO2NR6— wherein n is 0, 1 or 2.
摘要翻译:式(I)化合物是CRTH2受体的配体,可用于治疗呼吸系统疾病:其中R 1,R 2,R 3和R 4各自独立地为氢,C 1 -C 6烷基,完全或部分氟化的C 1 -C 6烷基,卤素, S(O)nR10,-SO2N(R10)2,-N(R10)2,-C(O)N(R10)2,-NR10C(O)R9,-CO2R10,-C(O) ,-CN或-OR11; 其中每个R 9独立地为C 1 -C 6烷基,芳基,杂芳基; R 10独立地是氢,C 1 -C 6烷基,芳基或杂芳基; R 11是氢,C 1 -C 6烷基,完全或部分氟化的C 1 -C 6烷基或基团-SO 2 R 9; n为0,1或2; R5是C1C6烷基,完全或部分氟化的C1C6烷基。 C 1 -C 6烯基,C 1 -C 6炔基,任选取代的芳基或任选取代的杂芳基; R6是氢,C1C6烷基或完全或部分氟化的C 1 -C 6烷基; R 7和R 5独立地为氢或C 1 -C 6烷基,或者R 7和R 5与它们所连接的原子一起形成环烷基; 且X为-CHR 6 - , - S(O)n - , - NR 6 SO 2 - 或-SO 2 NR 6 - ,其中n为0,1或2。
摘要:
A camera and related methodology in which a stitched panoramic image may be generated from a series of individual image frames onboard the camera and displayed on the camera display in a “real-time” environment. This allows the user to preview the completed panorama on the camera without the need to first upload the image frames onto a support computer. In this manner, the user is able to identify potential problems with the panorama and, if necessary, reacquire the individual image frames. In order to reduce the amount of onboard processor power and/or memory required, stitching may be performed on relatively lower resolution image frame files within the camera. When the preview indicates that image data for the panorama has been successfully acquired, then the full resolution image data may be uploaded to a support computer for processing.
摘要:
The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, B, D, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and methods of use thereof.
摘要:
The present invention provides a class of modified pyrimidine compounds, compositions and methods of using the compounds as glucocorticoid receptor modulators.
摘要:
The invention relates to N-substituted azaindolyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to N-substituted azaindolyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
摘要:
The invention relates to azaindolyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azaindolyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
摘要:
An orange juice beverage composition comprising orange juice and an added multivitamin and mineral component. The orange juice composition of the invention provides a delicious and refreshing way to give the body important vitamins and minerals for good health.
摘要:
The invention relates to azabenzothiophenyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzothiophenyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.